“One small way I am personally contributing to education is through sharing my take on academic and industry articles, using my medical background to boil down the jargon and pull out the benefits of the news for you.”

- Dan Platt, M.D.
Chief Medical Officer

Our Deskside with Dr. Dan section highlights cancer news in a way you can understand! Dan Platt, M.D. pulls the most relevant information out of the medical news and puts it into the correct context so that you can understand its importance for your disease.

Our goal is to share relevant medical news, information about clinical trials, and key takeaways from recent FDA approvals so that you can feel informed and empowered to get the best treatment possible.

Deskside with Dr. Dan articles are not offering medical advice but are created to provide information to empower decisions. You should always consult your oncology team with any questions that you might have.

Filtering

  • Acute Myeloid Leukemia
  • Chronic Myelomonocytic Leukemia
  • Lung Cancer
  • Lymphoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndromes
  • Non-Hodgkin Lymphoma
  • Skin Cancer

  • Clinical Trial
  • Coronavirus
  • FDA Approval

Is a Cancer Clinical Trial Right For You?

Get some details on whether a cancer clinical trial is right for you, including questions to answer and the need to gather as much information about where you're at in your cancer treatment journey.


Cancer Clinical Trials: Basics Explained (Phases & More)

Get the basics of cancer clinical trials explained by Dr. Dan in language you can understand. Phases are an important thing to know about - learn about all three in this resource.


What is a Cancer Clinical Trial and a Common Misconception

Get Dr. Dan's medical perspective about cancer clinical trials and why they're so important to help advance cancer treatments.


Cancer & COVID: What you Need to Know about Vaccination

Get Dr. Dan's medical perspective about key points that cancer patients and survivors need to know about COVID and vaccinations.


FDA approves nivolumab and ipilimumab for unresectable malignant pleural mesothelioma

Get Dr. Dan's medical perspective about the approval of nivolumab and ipilimumab for unresectable malignant pleural mesothelioma along with learning about what ‘non-epitheloid’ mesothelioma means.


FDA approves pralsetinib for lung cancer with RET gene fusions

Get Dr. Dan's medical perspective about the approval of pralsetinib and its treatment impact for lung cancer patients with RET gene fusions.


FDA approves Onureg (azacitidine tablets) for acute myeloid leukemia

Get Dr. Dan's medical opinion about the approval of Onureg (azacitidine tablets) and its impact for acute myeloid leukemia treatment.


FDA approves carfilzomib and daratumumab with dexamethasone for multiple myeloma

Get Dr. Dan's medical perspective about the approval of carfilzomib and daratumumab with dexamethasone for multiple myeloma treatment.


FDA granted accelerated approval to belantamab mafodotin-blmf for multiple myeloma

Get Dr. Dan's medical perspective about the accelerated approval to belantamab mafodotin-blmf for multiple myeloma treatment.


FDA grants accelerated approval to Tafasitamab-cxix for diffuse large B-cell lymphoma

Get Dr. Dan's medical perspective about the accelerated approval to to Tafasitamab-cxix for diffuse large B-cell lymphoma treatment.


 
Page 1 of 2